The recent review of a large series of patients with bilateral testiculargerm cell cancer treated at Memorial Sloan-Kettering Cancer Center (seearticle, page 8) is interesting and important to practicing urologists whoencounter this disease for three key reasons. First, this study, involving a very large series of patients with bilateraltestis tumors, corroborates the following facts that are well recognizedabout bilateral testicular cancer:
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.